These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22035209)

  • 21. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism.
    Robertson AL; Holmes GR; Bojarczuk AN; Burgon J; Loynes CA; Chimen M; Sawtell AK; Hamza B; Willson J; Walmsley SR; Anderson SR; Coles MC; Farrow SN; Solari R; Jones S; Prince LR; Irimia D; Rainger GE; Kadirkamanathan V; Whyte MK; Renshaw SA
    Sci Transl Med; 2014 Feb; 6(225):225ra29. PubMed ID: 24574340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage 3D migration: A potential therapeutic target for inflammation and deleterious progression in diseases.
    Gao WJ; Liu JX; Liu MN; Yao YD; Liu ZQ; Liu L; He HH; Zhou H
    Pharmacol Res; 2021 May; 167():105563. PubMed ID: 33746053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of immune modulators by smooth muscles.
    Singer CA; Salinthone S; Baker KJ; Gerthoffer WT
    Bioessays; 2004 Jun; 26(6):646-55. PubMed ID: 15170862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion.
    Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM
    Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The migration behavior of human vascular myocytes in culture--the screening potential of anti-arteriosclerosis active endogenous and exogenous substances].
    Bauriedel G; Ganesh S; Heimerl J; Brandl R; Becker HM; Höfling B
    Vasa Suppl; 1991; 33():147-8. PubMed ID: 1788649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural products: an evolving role in future drug discovery.
    Mishra BB; Tiwari VK
    Eur J Med Chem; 2011 Oct; 46(10):4769-807. PubMed ID: 21889825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation.
    Rom S; Zuluaga-Ramirez V; Reichenbach NL; Erickson MA; Winfield M; Gajghate S; Christofidou-Solomidou M; Jordan-Sciutto KL; Persidsky Y
    J Neuroinflammation; 2018 Jan; 15(1):25. PubMed ID: 29373982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
    Zhang FS; He QZ; Qin CH; Little PJ; Weng JP; Xu SW
    Acta Pharmacol Sin; 2022 Sep; 43(9):2173-2190. PubMed ID: 35046517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease.
    Perera AP; Kunde D; Eri R
    Curr Pharm Des; 2017; 23(16):2321-2327. PubMed ID: 28155620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANXA1
    Cardin LT; Sonehara NM; Mimura KK; Ramos Dinarte Dos Santos A; da Silva WA; Sobral LM; Leopoldino AM; da Cunha BR; Tajara EH; Oliani SM; Rodrigues-Lisoni FC
    Gene; 2017 May; 614():26-36. PubMed ID: 28257834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review.
    Constantinescu V; Haase R; Akgün K; Ziemssen T
    Ther Adv Neurol Disord; 2022; 15():17562864221133163. PubMed ID: 36437849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.